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Abstract
Obesity is a multi-factorial disease, resulting from genes, environment and behaviour interactions, and represents
the most common metabolic disorder in the Western Hemisphere. Its prevalence has dramatically risen during the
last three decades, reaching worldwide epidemic proportions. Recent cumulating evidence suggests that obesity
may represent an adverse health consequence of exposure during the critical developmental windows to environ-
mental chemicals disrupting endocrine function. Moreover, exposure to these chemicals seems to play a key role
in the development of obesity-related metabolic and cardiovascular diseases. Further research is needed to eluci-
date the relationship between this exposure and the obesity pandemia and the involved mechanisms as well as to
refine hazard identification.
Introduction
Obesity has recently become of great interest, due to a
significant increase of this pathology during the last three
decades both in children and adults. In fact, obesity
represents the most common metabolic disorder in the
Western industrialized countries, even if it is reaching
worldwide epidemic proportions involving also develop-
ing countries [1-4]. In addition, obesity is the major risk
factor for the development of insulin resistance, believed
to be an important link between obesity and the asso-
ciated metabolic syndrome diseases, known to reduce
quality and length of life and increase medical costs [5].
Since obesity is associated with sedentary lifestyle pat-
terns and inadequate dieting behaviours, obesity has
been thought to be explained by a prolonged positive
energy balance. However, this idea is now being chal-
lenged, as several social, economic and environmental
factors have been shown to influence human physical
growth and development, and obesity is one of the
many diseases shown to have a developmental origin. In
particular, obesity may be increasing as a function of
developmental nutrition and exposure to environmental
chemicals during the critical early life period. These
compounds interfere with the body’s adipose tissue biol-
ogy and interact with hormone receptors. They mimic
or antagonize the actions of endogenous hormones, thus
disrupting the programming of endocrine signalling
pathways during critical windows of early development
and differentiation. As a consequence, they are com-
monly defined as endocrine disrupting chemicals (EDC).
Infants and children may be considered a highly suscep-
tible population to EDC exposures [6-13]. At this
regard, it should be underlined that the adipose tissue
is an important endocrine tissue secreting obesity/
diabetes-related hormones and cytokines [14]. Develop-
mental exposure to EDC can create abnormalities within
the homeostatic control systems required to maintain a
normal body weight throughout life [15]. In addition,
recent evidence suggests that EDC may alter mechan-
isms involved in weight homeostasis, with consequent
weight gain by increased volume of adipose tissue [16].
Moreover, lipophilic environmental pollutants, including
persistent organic pollutants (POPs), pesticides, poly-
chlorinated biphenyls (PCBs) and polybrominated diphe-
nyl ethers (PBDEs) have been shown to accumulate in
adipose tissue after exposure. On the other hand,
increased adipose tissue results in altered storage of
lipophilic toxicants, that may disregulate the cyto-
chromes p450 gene expression profile in rat white adi-
pose tissue [14,17].
Finally, it has been hypothesized that not only envir-
onmental toxicants can modulate the genes expression,
but can also produce epigenetic effects, affecting in an
inheritable manner the metabolic status in humans
[18,19].
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Since the discover of hormone synthesis capacity, the
adipose tissue has conquered a central role in the com-
plex system of metabolism, hunger regulation, immunity
responses and fertility [20]. In fact, the adypocite pro-
duces the adipose derived hormones: leptin [21,22] and
adiponectin [22,23], playing a key role in regulating
energy balance, while the adipocytokines (resistin, che-
merin, visfatin, interleukin-6, plasminogen activator
inhibitor-1, retinol binding protein 4 and tumor necrosis
factor alpha, angiotensin) are also immunomodulating
agents [24]; anyway, all these substances are implicated
in developing metabolic syndrome [25]. Last, but not
least, in the fat tissue estradiol derives from aromatase
activity on testosterone [26]. Adipose cells bioactivity is
under the control of both hormonal (insulin, cortisol)
and nervous inputs (efferent vagus), and the tissue dif-
ferentiation too has been influenced by genes and their
transcriptional factors (peroxisome proliferator-activated
receptor g) and different signals, pro and anti-differen-
tiation, which are provided by locally produced growth
factors, cytokines, and circulating hormones (insulin,
insuline-like growth factor 1 - IGF1, growth hormone -
GH, thyroid hormones, glucocorticoids) [27,28].
Recently chemicals have been identified as one of the
environmental factors that may affect obesity and asso-
ciated diseases [29]. In particular, exposure to Bisphenol A
(BPA), one of the chemicals that we incidentally intake,
during the critical early life time period has been reported
to determine the development of obesity and hyperlipide-
mia. More specifically, BPA has been shown to affect the
glucose transport in adipocytes and at environmentally
relevant doses to inhibit the release of a key adipokine that
protects humans from metabolic syndrome [29-31].
In addition, several interesting associations between
different phthalate metabolites and obesity outcomes
have been reported [32]. These adverse human health
effects seem to be related to an interaction of these che-
micals with peroxisome proliferator-activated receptors
(PPARs), members of the nuclear receptor superfamily
[33]. Moreover, tributyltin (TBT) has been suggested to
be one of the environmental chemicals that lead to
excessive accumulation of adipose tissue [34].
In particular, exposure to EDC during critical periods
of development may result in adverse health effects that
may not be apparent until much later in life, including
obesity and diabetes [12].
More specifically, prenatal exposure to the dichlorodi-
phenyl-dichloroethylene (DDE) seems to be able to con-
tribute to the obesity epidemic in women [35] and
reduced growth in early life has been related to insulin
resistance [36]
More recently, alterations of adipogenesis, as well as
disruption of the adiposity gene expression and leptin
synthesis have been observed [37].
EDCs are also able to stimulate the glucocorticoid
receptor (GR) and as glucocorticoid signaling is central
to adipocyte differentiation, they are able to promote
adipogenesis in the 3T3-L1 Cell Line through the activa-
tion of the GR, thus leading to obesity [38].
A key role seems to play adiponectin, an adipocyte-
specific hormone that increases insulin sensitivity and
reduces tissue inflammation. As a consequence, any fac-
tor that suppresses adiponectin release could lead to
insulin resistance and increased susceptibility to obesity
and its associated diseases [31].
Furthermore, it has been shown that 2,3,7,8-tetra-
chlorodibenzo-p-dioxin (TCDD) induces complex
changes in enzymes of oxidative stress in adipocytes and
may cause insulin resistance [39,40].
Conclusions
Obesity has a clearly remarkable impact on health
related quality of life. However, the determinants of obe-
sity pandemic are many and yet poorly defined.
T h e r ei se m e r g i n ge v i d e n c et h a te x p o s u r et oe n v i r o n -
mental chemicals is associated with obesity and related
diseases, even if a cause-effect relationship between the
two events has still to be demonstrated. As a conse-
quence, further studies need to be carried out (i) to per-
form updated exposure measures for hazard and risk
estimation, (ii) to define the assessment of the potential
hazards emanating from these chemicals, and (iii) as no
risk may be justified when the health of humans is
involved, to find alternative and better quality materials
replacing those at this moment present on the market.
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